Pharsight

1. List of Bepreve drug patents

Patent Number	Company	Patent Title	Patent Expiry
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8877168	BAUSCH AND LOMB INC	Aqueous liquid preparations and light-stabilized aqueous liquid preparations	Jul, 2023 (6 months from now)
US8784789	BAUSCH AND LOMB INC	Aqueous liquid preparations and light-stabilized aqueous liquid preparations	Jan, 2025 (1 year, 11 months from now)

Market Authorisation Date: 08 September, 2009

Treatment: NA

Dosage: SOLUTION/DROPS;OPHTHALMIC

Strength	Submission Date	ANDA(s) Filed	First applicant approval	Last patent expiry	180 day status
0.015	09 Sep, 2013	3	03 May, 2019	19 Sep, 2019	Extingushed Deferred

Strength	Dosage	Availability
1.5%	SOLUTION/DROPS;OPHTHALMIC	Prescription

Patent Number	Company	Patent Title	Patent Expiry	Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10596107	BAUSCH AND LOMB INC	Ophthalmic suspension composition	Dec, 2036 (13 years from now)

Exclusivity	Exclusivity Expiration
New Strength (NS)	Feb 22, 2022

Market Authorisation Date: 22 February, 2019

Treatment: Treatment of post-operative inflammation and pain following ocular surgery

Dosage: GEL;OPHTHALMIC

Strength	Submission Date	ANDA(s) Filed	First applicant approval	Last patent expiry	180 day status
0.0038	14 Nov, 2022	1		23 Dec, 2036

Strength	Dosage	Availability
0.38%	GEL;OPHTHALMIC	Prescription

Patent Number	Company	Patent Title	Patent Expiry
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8293742	BAUSCH AND LOMB INC	Preferential vasoconstriction compositions and methods of use	Jul, 2030 (7 years from now)
US9259425	BAUSCH AND LOMB INC	Compositions and methods for eye whitening	Jul, 2030 (7 years from now)

Market Authorisation Date: 22 December, 2017

Treatment: Relieves redness of the eye due to minor eye irritations

Dosage: SOLUTION/DROPS;OPHTHALMIC

Strength	Submission Date	ANDA(s) Filed	First applicant approval	Last patent expiry	180 day status
0.00025	12 Jul, 2021	1		14 Jul, 2030

Strength	Dosage	Availability
0.025%	SOLUTION/DROPS;OPHTHALMIC	Over the counter

Patent Number	Company	Patent Title	Patent Expiry
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8636713	BAUSCH AND LOMB INC	Methods and devices for drug delivery to ocular tissue using microneedle	May, 2027 (4 years from now)
US9636332	BAUSCH AND LOMB INC	Methods and devices for the treatment of ocular diseases in human subjects	Nov, 2033 (10 years from now)
US9937075	BAUSCH AND LOMB INC	Apparatus and methods for ocular injection	May, 2034 (11 years from now)